RWB
TPTX

RMR Wealth Builders’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

RMR Wealth Builders’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-33
Closed -$3K – 776
2021
Q1 		$3K Hold
33
– – ﹤0.01% 722
2020
Q4 		$4K Buy
+33
New +$3.62K ﹤0.01% 472

Other funds holding TPTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

RMR Wealth Builders's TPTX Position: Q2 2021 in Review

RMR Wealth Builders sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q2 2021, closing a stake of 33 shares — an estimated $3K sold.

RMR Wealth Builders first reported a position in TPTX in Q4 2020 and held it in 2 quarters. The position peaked at $4K in Q4 2020. 190 funds tracked by Wall St. Rank hold TPTX as of Q2 2021.

  • RMR Wealth Builders reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • RMR Wealth Builders sold 33 Turning Point Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $3K.
  • RMR Wealth Builders first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • RMR Wealth Builders's Turning Point Therapeutics, Inc. Common Stock position peaked at $4K in Q4 2020.
  • 190 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q2 2021.

Based on RMR Wealth Builders's 13F filing for Q2 2021, filed 16 Aug 2021.